Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has three groups. People may be considered for one of the following:
Group 1 – Colorectal cancer patients with cachexia (significant unintended weight loss):
- Adults aged 18 or older
- People who have lost more than 5% of their body weight unintentionally in the last 6 months, OR lost more than 2% of their body weight unintentionally along with a low body weight (BMI under 20), OR lost more than 2% of their body weight unintentionally along with significant muscle loss
- People whose cachexia staging score (a medical measure of weight loss severity) falls between 5 and 12 (confirm with trial site)
Group 2 – Colorectal cancer patients without significant weight loss:
- Adults aged 18 or older
- People who have not experienced the levels of unintended weight loss described in Group 1
- People whose cachexia staging score falls between 0 and 2 (confirm with trial site)
Group 3 – Healthy individuals (no cancer):
- Adults aged 18 or older
Who may not be able to join:
The following criteria apply to all three groups:
- People with a mental health or psychological condition
- People who do not have sufficient knowledge of the Dutch language
- People with a muscle disease that affects the spine or lower limbs
- People who are bedridden and unable to move around independently
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kenneth Verboven, Professor, Hasselt University - REVAL
Phone: 0032479871509
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Skeletal muscle fiber typing; skeletal muscle nuclei; Inflammatory parameters; Mitochondrial morphology
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.